IVVD
Price
$0.44
Change
-$0.05 (-10.20%)
Updated
Dec 18 closing price
98 days until earnings call
LENZ
Price
$29.24
Change
-$3.17 (-9.78%)
Updated
Dec 18 closing price
Ad is loading...

IVVD vs LENZ

Header iconIVVD vs LENZ Comparison
Open Charts IVVD vs LENZBanner chart's image
Invivyd
Price$0.44
Change-$0.05 (-10.20%)
Volume$855.48K
CapitalizationN/A
LENZ Therapeutics
Price$29.24
Change-$3.17 (-9.78%)
Volume$228.93K
CapitalizationN/A
IVVD vs LENZ Comparison Chart
Loading...
IVVD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IVVD vs. LENZ commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVVD is a Hold and LENZ is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (IVVD: $0.44 vs. LENZ: $29.24)
Brand notoriety: IVVD and LENZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IVVD: 128% vs. LENZ: 154%
Market capitalization -- IVVD: $58.61M vs. LENZ: $891.3M
IVVD [@Biotechnology] is valued at $58.61M. LENZ’s [@Biotechnology] market capitalization is $891.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.1B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IVVD’s FA Score shows that 1 FA rating(s) are green whileLENZ’s FA Score has 0 green FA rating(s).

  • IVVD’s FA Score: 1 green, 4 red.
  • LENZ’s FA Score: 0 green, 5 red.
According to our system of comparison, LENZ is a better buy in the long-term than IVVD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IVVD’s TA Score shows that 4 TA indicator(s) are bullish while LENZ’s TA Score has 4 bullish TA indicator(s).

  • IVVD’s TA Score: 4 bullish, 5 bearish.
  • LENZ’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both IVVD and LENZ are a bad buy in the short-term.

Price Growth

IVVD (@Biotechnology) experienced а -23.87% price change this week, while LENZ (@Biotechnology) price change was -11.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.11%. For the same industry, the average monthly price growth was -2.34%, and the average quarterly price growth was +0.25%.

Reported Earning Dates

IVVD is expected to report earnings on Mar 27, 2025.

LENZ is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Biotechnology (-7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LENZ($891M) has a higher market cap than IVVD($58.6M). LENZ YTD gains are higher at: 1016.030 vs. IVVD (-88.716). LENZ has more cash in the bank: 217M vs. IVVD (107M). LENZ (1.58M) and IVVD (1.63M) have identical debt.
IVVDLENZIVVD / LENZ
Capitalization58.6M891M7%
EBITDA-232.89MN/A-
Gain YTD-88.7161016.030-9%
P/E RatioN/AN/A-
Revenue11.6MN/A-
Total Cash107M217M49%
Total Debt1.63M1.58M103%
TECHNICAL ANALYSIS
Technical Analysis
IVVDLENZ
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 10 days ago
83%
Bullish Trend 14 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 8 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
74%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Ad is loading...
IVVD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JHERX20.34-0.47
-2.26%
JHancock Equity Income C
LSVMX11.82-0.28
-2.31%
LSV US Managed Volatility Institutional
MGFSX9.80-0.30
-2.97%
MassMutual Global R5
POLRX45.29-1.58
-3.37%
Polen Growth Investor
BPSIX25.81-0.98
-3.66%
Boston Partners Small Cap Value II I

IVVD and

Correlation & Price change

A.I.dvisor indicates that over the last year, IVVD has been loosely correlated with ENTO. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if IVVD jumps, then ENTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVVD
1D Price
Change %
IVVD100%
-9.27%
ENTO - IVVD
57%
Loosely correlated
+2.28%
VIR - IVVD
37%
Loosely correlated
-2.65%
CDTX - IVVD
36%
Loosely correlated
-10.00%
AXON - IVVD
34%
Loosely correlated
-4.06%
MDGL - IVVD
32%
Poorly correlated
-4.35%
More

LENZ and

Correlation & Price change

A.I.dvisor tells us that LENZ and IVVD have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LENZ and IVVD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LENZ
1D Price
Change %
LENZ100%
-9.78%
IVVD - LENZ
31%
Poorly correlated
-9.27%
DSGN - LENZ
25%
Poorly correlated
-4.80%
TCRX - LENZ
24%
Poorly correlated
-2.36%
OCGN - LENZ
24%
Poorly correlated
-9.33%
GTBP - LENZ
23%
Poorly correlated
-17.67%
More